Text Size

Life After Cancer Treatment Study

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Temple University
ClinicalTrials.gov Identifier:
NCT00473941
First received: May 15, 2007
Last updated: August 24, 2011
Last verified: September 2010
History of Changes
  Purpose

The purpose of the study is to find new ways to improve the quality of life of people who have been treated for colon or rectal cancer.


Condition Intervention
Colorectal Cancer
 Behavioral: Expressive writing

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Expressive Writing and Adjustment to Colorectal Cancer

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Temple University:

Primary Outcome Measures:
  • Quality of Life measurements-Behavioral Intervention [ Time Frame: 2-Weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 150
Study Start Date: September 2005
Study Completion Date: August 2008
Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: 1
Writing in a journal 15 minutes a day
 Behavioral: Expressive writing
Quality of life measures through writing
No Intervention: 2
Control Writing in a journal 15 minutes a day
 Behavioral: Expressive writing
Quality of life measures through writing

Detailed Description:

Individuals who take part in the study can expect:

Two Interviews:

  • To be interviewed by our research staff over the phone. The interviews will include questions about your current quality of life and health.

Brief Writing in a Journal:

  • To write for 15 minutes twice a week for two weeks about aspects of your life.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Treated for stage I, II or III colon or rectal cancer in the past 5 years
  • Completed surgical treatment
  • Must be able to read and write in English

Exclusion Criteria:

  • History of other cancers, with the exception of non-melanoma skin cancer
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00473941

Locations
United States, Pennsylvania
Temple University
Philadelphia, Pennsylvania, United States, 19122
Sponsors and Collaborators
Temple University
Investigators
Principal Investigator: Stephen Lepore, Ph.D. Temple University
Principal Investigator: Tracey A Revenson, Ph.D Graduate College, City University of New York
  More Information

Additional Information:
Colon Cancer Alliance  This link exits the ClinicalTrials.gov site
Cancer Information Network  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Temple University
ClinicalTrials.gov Identifier: NCT00473941     History of Changes
Other Study ID Numbers: 1 R21-CA107428-01A2
Study First Received: May 15, 2007
Last Updated: August 24, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Temple University:
colorectal cancer
colon cancer
rectal cancer

Additional relevant MeSH terms:
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
 Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases

ClinicalTrials.gov processed this record on May 21, 2013